LAB logo

Standard BioTools (LAB) Revenue

Annual Revenue

$106.34 M
+$8.39 M+8.57%

31 December 2023

LAB Revenue Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Revenue

$44.97 M
+$7.76 M+20.87%

30 September 2024

LAB Quarterly Revenue Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM Revenue

$155.90 M
+$19.60 M+14.38%

30 September 2024

LAB TTM Revenue Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

LAB Revenue Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+8.6%+77.3%+48.2%
3 y3 years-23.0%+57.8%+13.9%
5 y5 years-5.9%+38.6%+33.0%

LAB Revenue High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-23.0%+8.6%-1.3%+139.5%at high+61.5%
5 y5 years-23.0%+8.6%-1.3%+139.5%at high+61.5%
alltimeall time-23.0%+1562.1%-1.3%+569.6%at high+1945.2%

Standard BioTools Revenue History

DateAnnualQuarterlyTTM
Sept 2024
-
$44.97 M(+20.9%)
$155.90 M(+14.4%)
June 2024
-
$37.20 M(-18.3%)
$136.30 M(+7.5%)
Mar 2024
-
$45.54 M(+61.6%)
$126.76 M(+19.2%)
Dec 2023
$106.34 M(+8.6%)
$28.19 M(+11.1%)
$106.34 M(+1.1%)
Sept 2023
-
$25.37 M(-8.3%)
$105.17 M(-0.3%)
June 2023
-
$27.67 M(+10.1%)
$105.45 M(+9.2%)
Mar 2023
-
$25.12 M(-7.0%)
$96.56 M(-1.4%)
Dec 2022
$97.95 M(-25.0%)
$27.02 M(+5.4%)
$97.95 M(-10.3%)
Sept 2022
-
$25.65 M(+36.6%)
$109.19 M(-2.6%)
June 2022
-
$18.78 M(-29.2%)
$112.05 M(-9.8%)
Mar 2022
-
$26.50 M(-30.7%)
$124.29 M(-4.8%)
Dec 2021
$130.58 M(-5.5%)
$38.27 M(+34.2%)
$130.58 M(-4.6%)
Sept 2021
-
$28.50 M(-8.1%)
$136.92 M(-7.7%)
June 2021
-
$31.02 M(-5.4%)
$148.28 M(+3.5%)
Mar 2021
-
$32.79 M(-26.5%)
$143.32 M(+3.7%)
Dec 2020
$138.14 M(+17.8%)
-
-
Dec 2020
-
$44.61 M(+11.9%)
$138.14 M(+9.7%)
Sept 2020
-
$39.86 M(+53.0%)
$125.98 M(+11.9%)
June 2020
-
$26.06 M(-5.6%)
$112.61 M(-1.9%)
Mar 2020
-
$27.62 M(-14.9%)
$114.75 M(-2.1%)
Dec 2019
$117.24 M(+3.8%)
-
-
Dec 2019
-
$32.44 M(+22.4%)
$117.24 M(+0.1%)
Sept 2019
-
$26.50 M(-6.0%)
$117.13 M(-2.1%)
June 2019
-
$28.20 M(-6.4%)
$119.59 M(+1.5%)
Mar 2019
-
$30.11 M(-6.8%)
$117.83 M(+4.3%)
Dec 2018
$112.96 M(+10.8%)
$32.33 M(+11.6%)
$112.96 M(+4.2%)
Sept 2018
-
$28.96 M(+9.6%)
$108.38 M(+4.0%)
June 2018
-
$26.43 M(+4.7%)
$104.17 M(+2.5%)
Mar 2018
-
$25.25 M(-9.0%)
$101.65 M(-0.3%)
Dec 2017
$101.94 M
$27.74 M(+12.1%)
$101.94 M(+2.7%)
Sept 2017
-
$24.75 M(+3.5%)
$99.28 M(+2.6%)
June 2017
-
$23.91 M(-6.3%)
$96.72 M(-4.2%)
DateAnnualQuarterlyTTM
Mar 2017
-
$25.53 M(+1.8%)
$100.98 M(-3.3%)
Dec 2016
$104.45 M(-8.9%)
$25.08 M(+13.0%)
$104.45 M(-5.1%)
Sept 2016
-
$22.19 M(-21.2%)
$110.08 M(-5.5%)
June 2016
-
$28.17 M(-2.9%)
$116.54 M(-0.4%)
Mar 2016
-
$29.00 M(-5.6%)
$116.99 M(+2.0%)
Dec 2015
$114.71 M(-1.5%)
$30.72 M(+7.3%)
$114.71 M(-2.4%)
Sept 2015
-
$28.64 M(+0.1%)
$117.48 M(-0.8%)
June 2015
-
$28.62 M(+7.1%)
$118.47 M(+0.9%)
Mar 2015
-
$26.73 M(-20.2%)
$117.46 M(+0.9%)
Dec 2014
$116.46 M(+63.6%)
$33.49 M(+13.0%)
$116.46 M(+12.1%)
Sept 2014
-
$29.64 M(+7.3%)
$103.85 M(+12.3%)
June 2014
-
$27.61 M(+7.3%)
$92.50 M(+12.3%)
Mar 2014
-
$25.72 M(+23.2%)
$82.37 M(+15.7%)
Dec 2013
$71.18 M(+36.0%)
$20.88 M(+14.2%)
$71.18 M(+7.9%)
Sept 2013
-
$18.29 M(+4.6%)
$65.96 M(+9.1%)
June 2013
-
$17.48 M(+20.3%)
$60.46 M(+8.1%)
Mar 2013
-
$14.54 M(-7.2%)
$55.92 M(+6.9%)
Dec 2012
$52.33 M(+22.1%)
$15.66 M(+22.5%)
$52.33 M(+5.4%)
Sept 2012
-
$12.78 M(-1.3%)
$49.67 M(+4.6%)
June 2012
-
$12.95 M(+18.3%)
$47.48 M(+5.3%)
Mar 2012
-
$10.95 M(-15.8%)
$45.11 M(+5.2%)
Dec 2011
$42.87 M(+27.7%)
$13.00 M(+22.7%)
$42.87 M(+6.6%)
Sept 2011
-
$10.60 M(+0.2%)
$40.22 M(+5.6%)
June 2011
-
$10.58 M(+21.6%)
$38.09 M(+7.2%)
Mar 2011
-
$8.70 M(-16.0%)
$35.54 M(+5.9%)
Dec 2010
$33.56 M(+32.1%)
$10.36 M(+22.3%)
$33.56 M(+8.9%)
Sept 2010
-
$8.47 M(+5.5%)
$30.83 M(+37.9%)
June 2010
-
$8.02 M(+19.5%)
$22.36 M(+56.0%)
Mar 2010
-
$6.72 M(-11.9%)
$14.34 M(+88.1%)
Dec 2009
$25.41 M(+65.6%)
$7.62 M
$7.62 M
Dec 2008
$15.35 M(+111.0%)
-
-
Dec 2007
$7.28 M(+13.7%)
-
-
Dec 2006
$6.40 M
-
-

FAQ

  • What is Standard BioTools annual revenue?
  • What is the all time high annual revenue for Standard BioTools?
  • What is Standard BioTools annual revenue year-on-year change?
  • What is Standard BioTools quarterly revenue?
  • What is the all time high quarterly revenue for Standard BioTools?
  • What is Standard BioTools quarterly revenue year-on-year change?
  • What is Standard BioTools TTM revenue?
  • What is the all time high TTM revenue for Standard BioTools?
  • What is Standard BioTools TTM revenue year-on-year change?

What is Standard BioTools annual revenue?

The current annual revenue of LAB is $106.34 M

What is the all time high annual revenue for Standard BioTools?

Standard BioTools all-time high annual revenue is $138.14 M

What is Standard BioTools annual revenue year-on-year change?

Over the past year, LAB annual revenue has changed by +$8.39 M (+8.57%)

What is Standard BioTools quarterly revenue?

The current quarterly revenue of LAB is $44.97 M

What is the all time high quarterly revenue for Standard BioTools?

Standard BioTools all-time high quarterly revenue is $45.54 M

What is Standard BioTools quarterly revenue year-on-year change?

Over the past year, LAB quarterly revenue has changed by +$19.60 M (+77.27%)

What is Standard BioTools TTM revenue?

The current TTM revenue of LAB is $155.90 M

What is the all time high TTM revenue for Standard BioTools?

Standard BioTools all-time high TTM revenue is $155.90 M

What is Standard BioTools TTM revenue year-on-year change?

Over the past year, LAB TTM revenue has changed by +$50.73 M (+48.23%)